Financial benefits for volunteers ... and closing the experiment when the number of participants reaches 15,000
Entering Abu Dhabi without testing for those subject to the Corona vaccine
Study participants will be the first to receive the vaccine once it is approved. From the source
The Department of Health in Abu Dhabi confirmed that the volunteers participating in the world's first clinical trial for the third phase of the inactive “Covid-19” virus have many advantages, including paying an acceptable amount for transportation and travel expenses and meals that were eaten while traveling, and during their presence. At the study site, throughout the extended visit days, according to the amount permitted by the Institutional Review Board.
The study sponsoring company will also bear the medical expenses incurred by the volunteer as a result of any injury or illness directly related to the study.
She pointed out that the volunteer receives full medical care, in the event of complications, and is exempt from conducting Corona examinations outside the scope of the experimental examination program, in addition to the freedom to enter Abu Dhabi without a PCR examination.
The number of registered volunteers exceeded 10,000 people, of whom more than 5,000 participants received one or more doses, during the first 20 days of the clinical trial launch.
Sheikh Abdullah bin Muhammad Al Hamed, head of the department, who was the first to volunteer in the clinical trials for the third phase of the inactive "Covid-19" vaccine, said: “After I and my brothers got the first dose of the vaccine, we got the second dose, and we did not complain of any symptoms. Pointing out that “the study participants will be the first to receive the vaccine as soon as it is approved, if vaccination is successful. They will be given freedom of movement between the emirates of the country, without the need to conduct a PCR examination. ”
The Acting Undersecretary of the Department, Dr. Jamal Al-Kaabi, confirmed that volunteers wishing to participate in the world's first clinical trial for the third phase of the inactive vaccine for the "Covid-19" virus will continue to receive, indicating that there is a "great demand for participation, as 1071 citizens and residents volunteered." Within one day, what constitutes an achievement for the medical staff based on the experience, and reflects the community interaction with it.
He said: “No serious symptoms were recorded, and the percentage of those who had symptoms did not exceed 14% of the vaccinated. They are simple symptoms, and they are gone, and there is no reason to fear, because the vaccination is safe, and we are currently in the process of researching its effectiveness and its ability to protect against the virus, ”noting that“ the volunteers participating in the study will have priority in getting vaccination, if the experiment is successful. , In appreciation of their participation ».
Al-Kaabi added: “The specialized field clinic in the exhibition grounds is the largest of its kind in the Middle East, and clinical trials for the third phase of a potential drug to treat (Corona) are being conducted,” indicating that about 5,000 participants received the vaccination.
He continued, "With the number of volunteers participating reaching 15 thousand participants, the experiment will be closed, and research will be directed to follow the symptoms."
For their part, the Department of Health in Abu Dhabi, the "G42 Healthcare" and the Abu Dhabi Health Services Company (SEHA), which are responsible for registering, examining and testing the volunteers participating in the third clinical trial of the inactive Covid-19 virus, indicated that "The risks related to the clinical study may include the occurrence of some common reactions upon receiving the vaccine: (pain, redness, stiffness and itching at the site of the vaccination). General reactions also include fever, headache, fatigue, nausea, diarrhea and coughing," indicating that "these symptoms do not require In general, treatment, it usually resolves on its own, while patients with severe symptoms are given treatment. ”
Volunteer terms
The Department of Health in Abu Dhabi set conditions for volunteers, including: That the study participant be a healthy person, between the ages of 18 and 60, that he is in good health, and that the volunteer capable of conceiving should not be pregnant or breastfeeding, when participating in the clinical trial.
In addition, the volunteer should not plan to become pregnant during the first three months of participating in the study.
The field clinic
The Abu Dhabi Department of Health, in cooperation with the G42 Healthcare Company and the Abu Dhabi Health Services Company (SEHA), has designated a specialized field clinic at the Abu Dhabi National Exhibition Center (ADNEC), to register volunteers to participate in the first clinical trial of the third phase of the inactivated virus vaccine. "Covid-19", by visiting them directly without the need to make appointments.
Abdullah Al Hamed:
"My brothers and I got the first and second doses of the vaccine, and we didn't complain of any symptoms."
Dr. Jamal Al Kaabi:
"The exhibition grounds clinic to conduct the third-phase experiments ... is the largest of its kind in the Middle East."
14%
Of the participants in the clinical trials experienced slight side effects .. they disappeared quickly.
5000
Participants received one or more doses within 20 days of the clinical trial launch.